Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $112.5000 (-6.29%) ($105.1000 - $125.0000) on Mon. May. 14, 2012. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.55% (three month average) | RSI | 48 | Latest Price | $112.5000(-6.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -2.7% a day on average for past five trading days. | Weekly Trend | CAPR declines -5.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) IWM(4%) EWP(3%) XAR(3%) XOP(3%) | Factors Impacting CAPR price | CAPR will decline at least -3.775% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) EWY(-1%) XLU(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.775% (StdDev 7.55%) | Hourly BBV | 0 () | Intraday Trend | -6.3% | | | |
|
Resistance Level | $138.69 | 5 Day Moving Average | $125.52(-10.37%) | 10 Day Moving Average | $133.8(-15.92%) | 20 Day Moving Average | $138.69(-18.88%) | To recent high | -61.2% | To recent low | 0% | Market Cap | $2.216b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |